July 14, 2015
F I N A N C I A L R E S U L T S
2Q15
 
   F   I   N    A   N    C    I   A   L   R    E   S   U    L   T   S
2Q15 Financial highlights
Note: For details on notable items affecting 2Q15 results, see note 8 on slide 20
1
See note 2 on slide 19
2
 
Represents estimated common equity Tier 1 (“CET1”) capital and ratio under the Basel III Fully Phased
-In capital rules to which the Firm will be subject to as of January 1, 2019. See note 3 on slide 19
3
 See note 1 on slide 19
4
 
Last twelve months (“LTM”). Net of employee issuances
 
5
See note 4 on slide 19
6
See note 1 on slide 20
7
Net of employee issuance
8
The repurchase amount is presented on a settlement-date basis

2Q15 net income of $6.3B and EPS of $1.54

Revenue of $24.5B
3

 Adjusted expense of $14.2B
5
and adjusted overhead ratio of 58%
5

Fortress balance sheet 

Balance sheet down by $123B YTD, driven by reduction in non-operating deposits

Core loans
6
 up 12% YoY and 5% QoQ

Basel III Fully Phased-In CET1 capital of $169B
2
, Advanced ratio of 11.0%
2
 and Standardized ratio of 11.2%
2

Delivered strong capital return

~$2.6B
7
 of net capital returned to shareholders in 2Q15, including $1.0B of net repurchases
8

Common dividend of $0.44 per share
Net payout ratio LTM 
4
52%
ROTCE 
1
14%
Overhead ratio 
3
59%
CET1 ratio 
2
11.0%
1
 
   F   I   N    A   N    C    I   A   L   R    E   S   U    L   T   S
$ O/(U)2Q15 1Q15 2Q14 Revenue (FTE)
1
$24,531 ($289)($806)Expense14,500 (383) (931) Credit costs935 (24) 243 Reported net income$6,290 $376 $310 Net income applicable to common stockholders$5,776 $324 $208 Reported EPS$1.54 $0.09 $0.08 ROE
2
11%11%11%ROTCE
2,3
14 14 14 Overhead ratio
1,2
59 60 61
Memo: Adjusted expense
4
$14,209 $13 ($553)
Memo: Adjusted overhead ratio
1,2,4
58%57%58%
2Q15 Financial results
1
Note: Certain prior period amounts have been revised; see note 2 on slide 20
1
See note 1 on slide 19
2
 Actual numbers for all periods, not over/(under)
3
See note 2 on slide 19
4
 See note 4 on slide 19
$mm, excluding EPS
2Q15 ROE O/H ratio
CCB19%56%CIB14%59%CB14%40% AM19%76%
2